Ambar Protein Industries Fair Value
Ambar Protein Industries (AMBARPIL) average fair value is ₹549.46 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹215.0 (+155.56%), fair value range ₹58.33–₹2451.42. Browse AMBARPIL complete financial statements for revenue, profit, balance sheet and cash flow data.
Fair Value Analysis Export
AMBARPIL Fair Value vs Current Price — Valuation Summary
AMBARPIL average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit Ambar Protein Industries share price today.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
AMBARPIL Fair Value Analysis — Data Sources & Coverage
Ambar Protein Industries financial data sources, valuation methods applied and sector benchmarks used. Read AMBARPIL dividend payout details for the complete payout history and dividend yield track record.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
AMBARPIL vs FMCG Sector Peers — P/E, P/B & Market Cap
Ambar Protein Industries P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Swasth Foodtech | SWASTH | -6.75 | 0.45 | ₹9 |
| Shreeji Global FMCG | SHETHJI | - | 3.68 | ₹436 |
| Kwality Walls | KWIL | -28.59 | 14.29 | ₹9,314 |
| Evexia Lifecar | EVEXIA | 158.0 | 0.55 | ₹310 |
| RKD Agri & Retail | RKDAGRRTL | -47.27 | 8.04 | ₹30 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.